Beijing Danatlas Pharmaceutical Technology Co. Ltd. has disclosed Werner syndrome ATP-dependent helicase (WRN; RECQ3; RECQL2) inhibitors reported to be useful for the treatment of cancer.
Leslie Cohen is the Editor-in-Chief of CWEB.com and DailyShocker.com. At CWEB, she also leads campaign development and marketing initiatives and manages teams across all the brands under the CWEB ...
Happenings in Boston’s life sciences ecosystem this past week include the departure of a general partner from Apple Tree Partners for another firm, Kronos Bio seeks "strategic alternatives" and new ...